Lung Persistence, Biodegradation, and Elimination of Graphene-Based Materials are Predominantly Size-Dependent and Mediated by Alveolar Phagocytes.
暂无分享,去创建一个
A. Bianco | Kostas Kostarelos | C. Bussy | M. A. Lucherelli | N. Lozano | L. V. D. de Luna | T. Loret | A. Fordham
[1] Kostas Kostarelos,et al. Lung recovery from DNA damage induced by graphene oxide is dependent on size, dose and inflammation profile , 2022, Particle and Fibre Toxicology.
[2] Helinor J Johnston,et al. Grouping MWCNTs based on their similar potential to cause pulmonary hazard after inhalation: a case-study , 2022, Particle and fibre toxicology.
[3] M. Prato,et al. Hazard assessment of abraded thermoplastic composites reinforced with reduced graphene oxide. , 2022, Journal of hazardous materials.
[4] Kostas Kostarelos,et al. Innate but Not Adaptive Immunity Regulates Lung Recovery from Chronic Exposure to Graphene Oxide Nanosheets , 2022, Advanced science.
[5] Xiaohui Xie,et al. Use of Nanoformulation to Target Macrophages for Disease Treatment , 2021, Advanced Functional Materials.
[6] A. Bianco,et al. How macrophages respond to two-dimensional materials: a critical overview focusing on toxicity , 2021, Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes.
[7] S. Aryal,et al. Biogenic and biomimetic nanocarrier-based interventions: focus on intracellular infections. , 2021, Nanomedicine.
[8] Liming Wang,et al. Molybdenum derived from nanomaterials incorporates into molybdenum enzymes and affects their activities in vivo , 2021, Nature Nanotechnology.
[9] A. Bianco,et al. Toxicological evaluation of highly water dispersible few-layer graphene in vivo , 2020, Carbon.
[10] Jyh-Ping Chen,et al. Mechanism of Nanoformulated Graphene Oxide-Mediated Human Neutrophil Activation. , 2020, ACS applied materials & interfaces.
[11] A. Bianco,et al. Comparative Effects of Graphene and Molybdenum Disulfide on Human Macrophage Toxicity. , 2020, Small.
[12] S. Haigh,et al. Splenic Capture and In Vivo Intracellular Biodegradation of Biological-Grade Graphene Oxide Sheets , 2020, ACS nano.
[13] B. Fadeel,et al. Size‐Dependent Pulmonary Impact of Thin Graphene Oxide Sheets in Mice: Toward Safe‐by‐Design , 2020, Advanced science.
[14] Yue Yu,et al. Rational chemical multifunctionalization of graphene interface enhances targeting cancer therapy. , 2020, Angewandte Chemie.
[15] B. K. Gupta,et al. Probing number of layers and quality assessment of mechanically exfoliated graphene via Raman fingerprint , 2020 .
[16] Ardemis A. Boghossian,et al. Banning carbon nanotubes would be scientifically unjustified and damaging to innovation , 2020, Nature Nanotechnology.
[17] Steffen Foss Hansen,et al. Carbon nanotubes added to the SIN List as a nanomaterial of Very High Concern , 2020, Nature Nanotechnology.
[18] Bengt Fadeel,et al. Nano-bio interactions: a neutrophil-centric view , 2019, Cell Death & Disease.
[19] Bengt Fadeel,et al. Safety Assessment of Graphene-Based Materials: Focus on Human Health and the Environment. , 2018, ACS nano.
[20] Bengt Fadeel,et al. Degradation of Single-Layer and Few-Layer Graphene by Neutrophil Myeloperoxidase. , 2018, Angewandte Chemie.
[21] B. Fadeel,et al. A blueprint for the synthesis and characterisation of thin graphene oxide with controlled lateral dimensions for biomedicine , 2018 .
[22] L. Ramakrishnan,et al. The Formation and Function of Granulomas. , 2018, Annual review of immunology.
[23] Bengt Fadeel,et al. Graphene Oxide Elicits Membrane Lipid Changes and Neutrophil Extracellular Trap Formation , 2018 .
[24] Tian Xia,et al. Surface Oxidation of Graphene Oxide Determines Membrane Damage, Lipid Peroxidation, and Cytotoxicity in Macrophages in a Pulmonary Toxicity Model. , 2018, ACS nano.
[25] Kostas Kostarelos,et al. Live Imaging of Label-Free Graphene Oxide Reveals Critical Factors Causing Oxidative-Stress-Mediated Cellular Responses. , 2017, ACS nano.
[26] I. Annesi-Maesano,et al. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris , 2017, European Respiratory Journal.
[27] U. Vogel,et al. Differences in inflammation and acute phase response but similar genotoxicity in mice following pulmonary exposure to graphene oxide and reduced graphene oxide , 2017, PloS one.
[28] T. Park,et al. Diverse Applications of Nanomedicine , 2017, ACS nano.
[29] Sang Jin Lee,et al. Pulmonary persistence of graphene nanoplatelets may disturb physiological and immunological homeostasis , 2017, Journal of applied toxicology : JAT.
[30] Zhongfan Liu,et al. Size and time dependent internalization of label-free nano-graphene oxide in human macrophages , 2017, Nano Research.
[31] Bengt Fadeel,et al. Detection of Endotoxin Contamination of Graphene Based Materials Using the TNF-α Expression Test and Guidelines for Endotoxin-Free Graphene Oxide Production , 2016, PloS one.
[32] Anna Huttenlocher,et al. Neutrophil migration in infection and wound repair: going forward in reverse , 2016, Nature Reviews Immunology.
[33] Jong Seong Lee,et al. 28-Day inhalation toxicity of graphene nanoplatelets in Sprague-Dawley rats , 2016, Nanotoxicology.
[34] Bengt Fadeel,et al. Biological interactions of carbon-based nanomaterials: From coronation to degradation. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[35] E. Petersen,et al. Biodistribution and toxicity of radio-labeled few layer graphene in mice after intratracheal instillation , 2015, Particle and Fibre Toxicology.
[36] Rui Liu,et al. Crucial Role of Lateral Size for Graphene Oxide in Activating Macrophages and Stimulating Pro-inflammatory Responses in Cells and Animals. , 2015, ACS nano.
[37] Alberto Bianco,et al. Carbon Nanotube Degradation in Macrophages: Live Nanoscale Monitoring and Understanding of Biological Pathway. , 2015, ACS nano.
[38] Dong‐Wan Kim,et al. Toxic response of graphene nanoplatelets in vivo and in vitro , 2015, Archives of Toxicology.
[39] Vincenzo Palermo,et al. Dispersibility-Dependent Biodegradation of Graphene Oxide by Myeloperoxidase. , 2015, Small.
[40] Hamidreza Ghandehari,et al. Nanoparticle Uptake: The Phagocyte Problem. , 2015, Nano today.
[41] Meiying Wang,et al. Use of a pro-fibrogenic mechanism-based predictive toxicological approach for tiered testing and decision analysis of carbonaceous nanomaterials. , 2015, ACS nano.
[42] Jae Hoon Shin,et al. 5-Day repeated inhalation and 28-day post-exposure study of graphene , 2015, Nanotoxicology.
[43] Vasileios Koutsos,et al. Minimal oxidation and inflammogenicity of pristine graphene with residence in the lung , 2014, Nanotoxicology.
[44] K Kostarelos,et al. Graphene for multi-functional synthetic biology: the last 'zeitgeist' in nanomedicine. , 2014, Bioorganic & medicinal chemistry letters.
[45] Yong Zhao,et al. Peroxidase-mediated biodegradation of carbon nanotubes in vitro and in vivo. , 2013, Advanced drug delivery reviews.
[46] Tatyana Chernova,et al. Pulmonary toxicity of carbon nanotubes and asbestos - similarities and differences. , 2013, Advanced drug delivery reviews.
[47] Abhilash Sasidharan,et al. Confocal Raman Imaging Study Showing Macrophage Mediated Biodegradation of Graphene In Vivo , 2013, Advanced healthcare materials.
[48] Moreno Meneghetti,et al. Evidencing the mask effect of graphene oxide: a comparative study on primary human and murine phagocytic cells. , 2013, Nanoscale.
[49] K. Donaldson,et al. Use of back-scatter electron signals to visualise cell/nanowires interactions in vitro and in vivo; frustrated phagocytosis of long fibres in macrophages and compartmentalisation in mesothelial cells in vivo , 2012, Particle and Fibre Toxicology.
[50] S. A. Hasan,et al. A natural vanishing act: the enzyme-catalyzed degradation of carbon nanomaterials. , 2012, Accounts of chemical research.
[51] Bengt Fadeel,et al. Impaired Clearance and Enhanced Pulmonary Inflammatory/Fibrotic Response to Carbon Nanotubes in Myeloperoxidase-Deficient Mice , 2012, PloS one.
[52] Ken Donaldson,et al. Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties. , 2012, ACS nano.
[53] Mark C Hersam,et al. Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung. , 2011, Nano letters.
[54] Joel G Pounds,et al. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies , 2010, Particle and Fibre Toxicology.
[55] Judith Klein-Seetharaman,et al. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. , 2010, Nature nanotechnology.
[56] Craig A. Poland,et al. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma , 2010, Particle and Fibre Toxicology.
[57] R. Löbenberg,et al. Targeted delivery of nanoparticles for the treatment of lung diseases. , 2008, Advanced drug delivery reviews.